MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma - Université Côte d'Azur Access content directly
Journal Articles Oncotarget Year : 2017

MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma

Dates and versions

hal-02531822 , version 1 (03-04-2020)

Identifiers

Cite

Alexandre Bozec, Joséphine Zangari, Mathilde Butori-Pepino, Marius I. Ilie, Salomé Lalvée, et al.. MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. Oncotarget, 2017, 8 (34), ⟨10.18632/oncotarget.19170⟩. ⟨hal-02531822⟩
54 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More